Home > Healthcare & Medical Devices > Stroke Management Market

Stroke Management Market - By Type (Ischemic, Hemorrhagic, Transient Ischemic Attack), By Product (Diagnostic Devices, Therapeutic Devices), By End-use (Hospitals, Diagnostic Centers) & Forecast, 2023-2032

  • Report ID: GMI3550
  • Published Date: Nov 2022
  • Report Format: PDF

Industry Overview

Stroke Management Market size was valued at over USD 37 billion in 2022. Driven by the increasing instances of cardiovascular ailments, the market is poised to grow at 6% CAGR from 2023 to 2032.

Stroke Management Market

To get more details on this report: Request Free Sample PDF

Rising cases of cardiovascular diseases (CVDs) across the globe are fuelling the industry outlook. As per CDC, in 2020, nearly 697,000 people died from cardiac disease in the U.S., accounting for 1 in every 5 deaths. Meanwhile, the WHO estimates that CVDs lead to approximately 17.9 million deaths yearly, accounting for nearly 31% of mortalities globally. Cardiac ailments increase the risks of stroke and coronary artery disease, often leading to mortalities or other health complications that lead to disabilities, creating a notable demand for effective stroke management products and services.

The high cost of stroke management procedures may hamper stroke management market development

Stroke is one of the prominent causes of disability and neurological diagnosis among patients. As a result, it is commonly regarded to bring substantial economic burden, which may impede industry statistics. Estimates suggest that the global annual healthcare costs associated with strokes will likely surpass USD 240 billion by the end of 2030. Meanwhile, the growing adoption of mechanical thrombectomy over medical therapy, which entails an interventional procedure and high cost of imaging studies, medical devices, and angiography suite time, may further dampen market expansion.

Increasing mortality rate to bolster transient ischemic attack segment growth

Stroke Management Market , by Type

To get more details on this report: Request Free Sample PDF

On the basis of type, the industry is categorized into hemorrhagic, ischemic, transient ischemic attack, and others. Amongst them, the market share from transient ischemic attack (TIA) segment is projected to surpass USD 1.5 billion by 2032. The segment outlook is fuelled by the increasing mortality rate associated with the disease, which is fostering the adoption of stroke management devices. In addition, the rising inclination towards catheter-based devices for interventional procedures to remove thrombi is also poised to accelerate market statistics. 

Rising occurrences of aneurysm to impel the demand for therapeutic devices

On the basis of product, the market is bifurcated into therapeutic devices and diagnostic devices. The therapeutic devices segment is expected to surpass USD 11.5 billion by 2032. Segmental growth is slated to be driven by the increasing number of patients suffering from an aneurysm. As per the Brain Aneurysm Foundation, ruptured brain aneurysms are responsible for 3-5% of all new stroke cases. To that end, increasing use of therapeutic devices such as surgical clipping is also likely to outline the segment outlook. 

Favorable reimbursement policies to foster the hospital end-use segment demand

Stroke Management Market, by End-use

To get more details on this report: Request Free Sample PDF

With respect to end-use, stroke management market is segmented into ambulatory surgery centers, diagnostic centers, hospitals, and others. The hospital segment accounted for over 39% market share in 2022. The segment is forecast to depict strong growth owing to increasing hospital admissions, which are in-turn driven by the increasing accessibility to favorable reimbursement policies for treatment procedures performed in hospital settings. As per the American Hospital Association, in 2022, over 33.3 million heart attack and stroke patients were hospitalized in the U.S. alone.

Increasing funding from private and public sectors to strengthen APAC stroke management market size

Stroke Management Market, by Region

Asia Pacific stroke management market share is expected to surpass USD 17 billion by 2032. Increasing investments from both public as well as private organizations towards initiatives that are designed to spread more awareness about cardiovascular ailments will drive regional market share. Meanwhile, growing efforts from leading regional industry players towards capturing a higher market share in emerging Asia-Pacific nations will also define segment expansion.

Mergers and acquisitions to shape the stroke management market landscape

Leading contenders in the stroke management market include names such as GE Healthcare, Boston Scientific Corporation, Medtronic, Johnson & Johnson, Penumbra, Inc., among others. Many enterprises are increasingly focusing on takeovers and mergers to consolidate product portfolios and production capacities. For instance, in December 2021, Integer Holdings Corporation, a leader in advanced medical device design, acquired Oscor, Inc., another advanced medical device designer. The deal is expected to help Integer expand its product catalogue for cardiovascular and neurostimulation devices and also grow its manufacturing capacity.

Impact of COVID-19 on the stroke management market trends

The COVID-19 pandemic had a major impact on the global market, with several countries reporting a drop in the volume of acute stroke patients. Moreover, a major decline in stroke consultations and reperfusion treatment rates, particularly thrombolysis was observed in response to government guidelines to mitigate COVID-19.

In March of 2020, Italy saw a 28% decrease in patient visits to its Emergency Department for stroke management, with many avoiding hospital visits due to fear and stay-at-home orders. However, with successful vaccination drives mitigating the risk of hospitals being overwhelmed, healthcare capacity is slowly being redirected towards patients suffering from other ailments.

The stroke management market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027 for the following segments:

Click here to Buy Section of this Report

By Type

  • Ischemic
  • Hemorrhagic
  • Transient Ischemic Attack (TIA)
  • Others

By Product

  • Diagnostic Devices
    • Magnetic Resonance Imaging (MRI)
    • Computed Tomography Scan (CT scan)
    • Electrocardiography
    • Carotid Ultrasound
    • Cerebral Angiography
    • Others
  • Therapeutic Devices
    • Stent retriever
    • Surgical clips
    • Embolic coils
    • Flow diverters
    • Aspiration catheters
    • Others

By End-use

  • Hospitals
  • Ambulatory Surgery Centers
  • Diagnostic Centers
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Spain
    • Italy
    • Russia
    • Poland
    • Netherlands
    • Others
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Malaysia
    • Thailand
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • Others
Authors: Rupali Swain

Frequently Asked Questions (FAQ) :

Global market for stroke management held a valuation of over USD 37 billion in 2022 and is poised to grow at 6% CAGR between 2023 and 2032.

APAC market for stroke management is poised to surpass USD 17 billion by 2032, driven by rising public and private sector spending on generating awareness about cardiovascular disorders and the rising market player focus on emerging Asia-Pacific countries.

The transient ischemic attack (TIA) segment is expected to cross USD 1.5 billion by 2032, fueled by escalating the adoption of stroke management devices and growing preference for catheter-based devices for interventional procedures.

Some of the leading market players include Asahi Intecc CO., LTD, GE Healthcare, Abbott, Johnson & Johnson, Medtronic, Boston Scientific Corporation, Penumbra, Inc., among others.

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 14
  • Tables & Figures: 381
  • Countries covered: 25
  • Pages: 280
Inquiry Before Buying

Budget constraints? Get in touch with us for special pricing

Request Discount